Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

The Effects of Kinesio Taping on Hallux Valgus

13 maggio 2026 aggiornato da: Muhammed Burak Örten

The Effects of Kinesio Taping on Hallux Valgus Angle, Plantar Pressure Measurements, and Foot-Related Quality of Life in Individuals With Hallux Valgus

Purpose: The purpose of this study is to evaluate the clinical, radiological, and biomechanical effects of Kinesio Taping (KT) when integrated into a standard exercise program for individuals with Hallux Valgus (HV). Hallux valgus is a progressive deformity of the first metatarsophalangeal (MTP) joint that leads to pain, functional impairment, and gait disturbances. While conservative treatments like exercises are common, the specific impact of KT on dynamic plantar pressure distribution and radiological angles requires further objective evidence.

Methods: A total of 50 participants (aged 18-65) with mild-to-moderate HV are randomized into two groups. Group 1 receives a 4-week intervention consisting of specialized Kinesio Taping applied once a week plus a daily home exercise program. Group 2 performs the same home exercise program only.

Assessments: Assessments include radiological measurements (Hallux Valgus Angle - HVA and Intermetatarsal Angle - IMA), clinical pain levels via the Visual Analog Scale (VAS), functional status via the American Orthopaedic Foot and Ankle Society (AOFAS-MTP-IP) scale, and dynamic pedobarographic analysis using the Zebris® FDM-2 system. Physical exercise capacity is also measured by the 6-Minute Walk Test (6MWT).

Panoramica dello studio

Stato

Completato

Condizioni

Descrizione dettagliata

Background and Rationale:

Hallux valgus (HV) is a progressive musculoskeletal deformity characterized by the lateral deviation of the great toe and medial deviation of the first metatarsal. This pathology significantly impairs the first metatarsophalangeal (MTP) joint dynamics, medial longitudinal arch structure, and load-bearing mechanisms. Clinical evidence suggests that HV leads to foot pain, functional limitations, impaired balance, and an increased risk of falls. While various conservative treatments exist, Kinesio Taping (KT) has gained popularity for providing dynamic support without restricting joint range of motion. This study was conducted to evaluate the corrective, functional, and biomechanical efficacy of KT integrated into an exercise program.

Study Design:

This study utilized a prospective, randomized, controlled, and assessor-blinded design. It was conducted in accordance with the Declaration of Helsinki and approved by the local Clinical Research Ethics Committee.

Participant Selection and Randomization:

Symptomatic individuals (VAS score ≥ 3) aged 18-65 with mild-to-moderate HV (HVA 15°-40°, IMA 9°-16°) were recruited from the physical medicine and rehabilitation outpatient clinic. Participants were excluded if they had neuromuscular diseases, previous foot surgery, acute inflammatory conditions, malignancies, or skin lesions in the application area. Randomization was performed using a web-based random sequence generator (random.org), and participants were assigned to groups via sequentially numbered, opaque, sealed envelopes to ensure allocation concealment.

Intervention Protocols:

Kinesio Taping Group (Group 1): Participants received four sessions of specialized KT (Kinesio Tex Gold®) applied once a week by a certified physician. A combined "I" and "X" strip configuration was used. The "I" strip was applied from the medial proximal phalanx to the posterior calcaneus with 50% mechanical correction tension. The "X" strip was applied over the first MTP joint to provide rotational control and support the transverse arch.

Exercise Protocol: Both groups followed a standardized 4-week home exercise program (2 sets of 10 repetitions daily). The protocol included "short foot" exercises, toe spreading, modified heel raises, and isolated toe extensions, supported by visual brochures and exercise diaries.

Control Group (Group 2): Participants performed the same 4-week exercise program without any taping intervention.

Assessment and Data Collection:

Assessments were conducted at baseline and after the 4-week intervention period.

Radiological Assessment: Hallux Valgus Angle (HVA) and Intermetatarsal Angle (IMA) were measured on standard weight-bearing anteroposterior radiographs by a blinded radiologist.

Pedobarographic Analysis: Dynamic gait and static posture analyses were performed using the Zebris® FDM-2 Pressure Analysis System. Data collection included a 10-second static stance and a 20-second barefoot dynamic gait analysis. A blinded physiotherapist processed the data using 3-region (hindfoot, midfoot, forefoot) and 7-region (medial/lateral heel, midfoot, medial/internal/lateral forefoot, and toes) protocols to determine peak maximum force and pressure distribution.

Clinical and Functional Measures: Pain intensity was recorded using the Visual Analog Scale (VAS). Functional status and foot-related quality of life were evaluated using the AOFAS-MTP-IP scale. Functional exercise capacity was measured via the 6-Minute Walk Test (6MWT) in a 10-meter standardized corridor.

Statistical Analysis:

The target sample size was determined as 50 participants (25 per group) based on a power analysis (G*Power 3.1) to achieve a power of 0.95. Data analysis was performed using R software (v4.4.1). Intragroup and intergroup comparisons were conducted using parametric (Independent and Paired Samples T-tests) or non-parametric tests (Mann-Whitney U and Wilcoxon tests) depending on the normality of data distribution. Statistical significance was set at p < 0.05.

Tipo di studio

Interventistico

Iscrizione (Effettivo)

50

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

    • Kocasinan
      • Kayseri, Kocasinan, Turchia (Türkiye)
        • Kayseri City Hospital

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Adulto
  • Adulto più anziano

Accetta volontari sani

No

Descrizione

Inclusion Criteria:

  • Women and men between the ages of 18-65
  • People with mild or moderate stage hallux valgus
  • People with VAS 3 and above

Exclusion Criteria:

  • Neuromuscular diseases that limit clinical exercise, uncontrolled psychiatric diseases or cognitive-cognitive disorders
  • Patients who have received physiotherapy to the foot area in the last 6 months
  • Presence of uncontrolled systemic diseases
  • Malignancy
  • Infection
  • High fever
  • Acute inflammatory rheumatic diseases
  • Acute peripheral vascular diseases
  • Patients with previous foot surgery
  • Patients with skin lesions in the foot area
  • Patients with rheumatoid arthritis
  • Patients without cooperation and compliance
  • Patients who did not agree to participate in the study
  • Patients with foot osteoarthritis
  • Patients with gouty arthritis
  • Patients allergic to kinesio tape material
  • Patients with hallux rigidus
  • Other lower extremity alignment disorders (genu varum/valgum, developmental hip dysplasia etc.)
  • People who have a history of using foot orthosis

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Trattamento
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione parallela
  • Mascheramento: Separare

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Sperimentale: Kinesio Taping and Exercise
While applying kinesio tape, individuals will also be given home exercises.
Kinesio taping for correcting hallux valgus deformity
Patients will do exercise for correcting hallux valgus deformity
Comparatore attivo: Exercise
Individuals will be given only home exercises
Patients will do exercise for correcting hallux valgus deformity

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Visual Analog Scale (VAS)
Lasso di tempo: 4 weeks
A type of pain scale. It has a value between 0 and 10. A decrease in the value is associated with improvement.
4 weeks
Hallux Valgus and Intermetatarsophalengeal Angle
Lasso di tempo: 4 weeks
4 weeks

Misure di risultato secondarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Six Minute Walk Test
Lasso di tempo: 4 weeks
4 weeks
Plantar Pressure Measurements
Lasso di tempo: 4 weeks
4 weeks
Plantar Force Measurements
Lasso di tempo: 4 weeks
4 weeks
American Orthopaedic Foot and Ankle Society Metatarsophalangeal - Interphalangeal Scale (AOFAS-MTP-IP)
Lasso di tempo: 4 weeks
It has a value between 0 and 100. An increase in the value is associated with improvement.
4 weeks
Foot Rotation Degree
Lasso di tempo: 4 weeks
4 weeks

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

25 dicembre 2024

Completamento primario (Effettivo)

1 dicembre 2025

Completamento dello studio (Effettivo)

1 dicembre 2025

Date di iscrizione allo studio

Primo inviato

4 maggio 2026

Primo inviato che soddisfa i criteri di controllo qualità

13 maggio 2026

Primo Inserito (Effettivo)

15 maggio 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

15 maggio 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

13 maggio 2026

Ultimo verificato

1 maggio 2026

Maggiori informazioni

Termini relativi a questo studio

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .

Sottoscrivi